Bronnen:
- Sandborn WJ ,Bhandari BR, Randall C. et al. Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease. Journal of Crohn's and Colitis. 14 Mei 2018. doi.org/10.1093/ecco-jcc/jjy049